Sun Biopharma Appoints CFO
This article was originally published in Scrip
Sun BioPharma, Inc., a company focused on pancreatic diseases, has appointed Scott Kellen vice-president of finance and chief financial officer (CFO) effective immediately. Kellen brings over 20 years of healthcare, corporate finance and capital markets experience to Sun Biopharma and joins the company from Kips Bay Medical, Inc., a medical device company, where he was chief operating officer and CFO. Previously, Kellen was director of finance at Transoma Medical, Inc., and corporate controller for ev3, Inc. during its IPO and follow-on offerings.